 Nadir El Sharawi
Concepts (116)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cesarean Section | 16 | 2025 | 183 | 3.470 |
Why?
| | Placenta Accreta | 5 | 2023 | 26 | 1.990 |
Why?
| | Anesthesia, Obstetrical | 5 | 2025 | 39 | 1.510 |
Why?
| | Anesthesia, Spinal | 3 | 2022 | 17 | 1.190 |
Why?
| | Anesthesia, Epidural | 3 | 2023 | 26 | 1.100 |
Why?
| | Pregnancy | 22 | 2025 | 2658 | 1.090 |
Why?
| | Placenta Previa | 2 | 2023 | 7 | 1.020 |
Why?
| | Anesthetics, Local | 3 | 2022 | 77 | 0.710 |
Why?
| | Analgesia, Obstetrical | 3 | 2023 | 26 | 0.560 |
Why?
| | Analgesics, Opioid | 3 | 2021 | 587 | 0.520 |
Why?
| | Female | 25 | 2025 | 28055 | 0.490 |
Why?
| | Postpartum Period | 4 | 2021 | 107 | 0.480 |
Why?
| | Emergency Nursing | 1 | 2015 | 8 | 0.460 |
Why?
| | Nurse Anesthetists | 1 | 2015 | 3 | 0.450 |
Why?
| | Procaine | 2 | 2022 | 10 | 0.440 |
Why?
| | Pain, Postoperative | 3 | 2021 | 169 | 0.430 |
Why?
| | Fentanyl | 2 | 2022 | 39 | 0.420 |
Why?
| | Hysterectomy | 4 | 2023 | 90 | 0.420 |
Why?
| | Labor, Obstetric | 1 | 2023 | 43 | 0.400 |
Why?
| | Infectious Disease Transmission, Patient-to-Professional | 2 | 2021 | 19 | 0.380 |
Why?
| | Cerclage, Cervical | 1 | 2022 | 8 | 0.380 |
Why?
| | Morphine | 2 | 2021 | 103 | 0.370 |
Why?
| | Humans | 27 | 2025 | 52114 | 0.370 |
Why?
| | Convalescence | 1 | 2021 | 6 | 0.350 |
Why?
| | Puerperal Disorders | 1 | 2021 | 28 | 0.350 |
Why?
| | Uterus | 1 | 2021 | 88 | 0.350 |
Why?
| | Sodium Bicarbonate | 1 | 2021 | 9 | 0.350 |
Why?
| | Anesthetics | 1 | 2021 | 36 | 0.340 |
Why?
| | Postpartum Hemorrhage | 1 | 2021 | 38 | 0.340 |
Why?
| | Lidocaine | 1 | 2021 | 46 | 0.340 |
Why?
| | Pain Management | 1 | 2022 | 175 | 0.340 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2015 | 503 | 0.340 |
Why?
| | Epinephrine | 1 | 2021 | 92 | 0.330 |
Why?
| | Balloon Occlusion | 1 | 2020 | 17 | 0.330 |
Why?
| | Outpatients | 1 | 2021 | 125 | 0.330 |
Why?
| | Pain Measurement | 1 | 2021 | 256 | 0.330 |
Why?
| | Intubation, Intratracheal | 1 | 2021 | 117 | 0.320 |
Why?
| | Pain | 1 | 2022 | 353 | 0.310 |
Why?
| | Postoperative Care | 1 | 2020 | 102 | 0.310 |
Why?
| | Checklist | 1 | 2019 | 40 | 0.300 |
Why?
| | Nerve Block | 1 | 2019 | 42 | 0.290 |
Why?
| | Heroin | 1 | 2018 | 16 | 0.290 |
Why?
| | Recovery of Function | 1 | 2019 | 201 | 0.290 |
Why?
| | Endovascular Procedures | 1 | 2020 | 179 | 0.280 |
Why?
| | Physicians | 1 | 2021 | 235 | 0.270 |
Why?
| | Delivery, Obstetric | 2 | 2020 | 122 | 0.270 |
Why?
| | Respiratory Insufficiency | 1 | 2018 | 115 | 0.270 |
Why?
| | Medical Records | 1 | 2016 | 86 | 0.250 |
Why?
| | International Classification of Diseases | 1 | 2016 | 67 | 0.250 |
Why?
| | Quality of Life | 1 | 2021 | 878 | 0.230 |
Why?
| | Placenta | 2 | 2023 | 152 | 0.230 |
Why?
| | Neuromuscular Blockade | 1 | 2025 | 13 | 0.230 |
Why?
| | Cardiovascular Diseases | 1 | 2020 | 493 | 0.220 |
Why?
| | Renal Insufficiency | 1 | 2025 | 110 | 0.210 |
Why?
| | Patient Discharge | 1 | 2016 | 322 | 0.210 |
Why?
| | Research Design | 2 | 2025 | 367 | 0.210 |
Why?
| | Consensus | 3 | 2022 | 190 | 0.200 |
Why?
| | Obstetrics | 1 | 2023 | 89 | 0.180 |
Why?
| | Retrospective Studies | 4 | 2025 | 6610 | 0.170 |
Why?
| | Mothers | 1 | 2023 | 266 | 0.170 |
Why?
| | Postnatal Care | 1 | 2020 | 15 | 0.160 |
Why?
| | Parturition | 1 | 2020 | 50 | 0.160 |
Why?
| | Analgesia, Epidural | 2 | 2021 | 28 | 0.160 |
Why?
| | Psychometrics | 2 | 2021 | 229 | 0.150 |
Why?
| | Adult | 6 | 2025 | 14095 | 0.150 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2020 | 81 | 0.150 |
Why?
| | Reproducibility of Results | 3 | 2021 | 1214 | 0.150 |
Why?
| | Inpatients | 1 | 2020 | 206 | 0.150 |
Why?
| | Risk Factors | 2 | 2025 | 3922 | 0.140 |
Why?
| | Length of Stay | 2 | 2021 | 666 | 0.140 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 177 | 0.130 |
Why?
| | Coronavirus Infections | 1 | 2020 | 188 | 0.130 |
Why?
| | Punctures | 1 | 2023 | 52 | 0.100 |
Why?
| | Infant, Newborn | 3 | 2021 | 2859 | 0.100 |
Why?
| | Prospective Studies | 2 | 2025 | 2424 | 0.100 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2021 | 20 | 0.090 |
Why?
| | Bupivacaine | 1 | 2022 | 29 | 0.090 |
Why?
| | Clinical Competence | 1 | 2015 | 396 | 0.090 |
Why?
| | Sensory Thresholds | 1 | 2021 | 15 | 0.090 |
Why?
| | Touch | 1 | 2021 | 23 | 0.090 |
Why?
| | Anesthesia, General | 1 | 2022 | 97 | 0.090 |
Why?
| | Double-Blind Method | 1 | 2022 | 718 | 0.080 |
Why?
| | Resuscitation | 1 | 2020 | 70 | 0.080 |
Why?
| | Critical Care | 2 | 2023 | 214 | 0.080 |
Why?
| | Patient Selection | 1 | 2021 | 265 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2021 | 5456 | 0.080 |
Why?
| | Aorta | 1 | 2020 | 170 | 0.080 |
Why?
| | Patient Readmission | 1 | 2021 | 243 | 0.080 |
Why?
| | Anesthesia | 1 | 2018 | 65 | 0.070 |
Why?
| | Massachusetts | 1 | 2016 | 35 | 0.060 |
Why?
| | Michigan | 1 | 2016 | 26 | 0.060 |
Why?
| | Morbidity | 1 | 2016 | 140 | 0.060 |
Why?
| | United States | 2 | 2021 | 5168 | 0.060 |
Why?
| | Queensland | 1 | 2025 | 4 | 0.060 |
Why?
| | Prevalence | 1 | 2018 | 1013 | 0.060 |
Why?
| | Neostigmine | 1 | 2025 | 4 | 0.060 |
Why?
| | Atracurium | 1 | 2025 | 4 | 0.060 |
Why?
| | Neuromuscular Blocking Agents | 1 | 2025 | 9 | 0.060 |
Why?
| | Multicenter Studies as Topic | 1 | 2025 | 112 | 0.060 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2025 | 7 | 0.060 |
Why?
| | Arkansas | 1 | 2021 | 2016 | 0.060 |
Why?
| | Glomerular Filtration Rate | 1 | 2025 | 127 | 0.060 |
Why?
| | Time Factors | 1 | 2021 | 2970 | 0.060 |
Why?
| | Middle Aged | 2 | 2025 | 13028 | 0.050 |
Why?
| | Blood Transfusion | 1 | 2023 | 129 | 0.050 |
Why?
| | Delphi Technique | 1 | 2022 | 64 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2018 | 1071 | 0.040 |
Why?
| | Registries | 1 | 2025 | 629 | 0.040 |
Why?
| | Young Adult | 1 | 2021 | 4307 | 0.040 |
Why?
| | Bibliometrics | 1 | 2020 | 17 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 1665 | 0.040 |
Why?
| | Family | 1 | 2020 | 170 | 0.040 |
Why?
| | Male | 2 | 2025 | 26652 | 0.040 |
Why?
| | Health Personnel | 1 | 2020 | 251 | 0.030 |
Why?
| | Pandemics | 1 | 2020 | 579 | 0.030 |
Why?
| | Aged | 1 | 2025 | 10142 | 0.020 |
Why?
|
|
El Sharawi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|